The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.
Propanc Biopharma, Inc. quick ratio for the quarter ending 2023-03-31 was 0.03, a 29.07% decline year-over-year.
Propanc Biopharma, Inc. quick ratio for the quarter ending 2022-12-31 was 0.01, a 66.22% decline year-over-year.
Propanc Biopharma, Inc. quick ratio for the quarter ending 2022-09-30 was 0.01, a 64.47% decline year-over-year.
Propanc Biopharma, Inc. quick ratio for the quarter ending 2022-06-30 was 0, a 81.40% increase year-over-year.
Propanc Biopharma, Inc. quick ratio for fiscal 2022 was 0, a 81.40% increase from fiscal 2021.
Propanc Biopharma, Inc. quick ratio for fiscal 2021 was 0, a 95.91% decline from fiscal 2020.
Propanc Biopharma, Inc. quick ratio for fiscal 2020 was 0.02.
Propanc Biopharma, Inc. quick ratio for fiscal 2014 was 0.06, a change of 0.06 from fiscal 2013.